financetom
Business
financetom
/
Business
/
Profusa Closes Merger With NorthView Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Profusa Closes Merger With NorthView Acquisition
Jul 11, 2025 1:48 PM

04:22 PM EDT, 07/11/2025 (MT Newswires) -- Profusa (PFSA) said Friday it has closed its business combination with special purpose acquisition company NorthView Acquisition.

The combined company will operate under the Profusa name, with its shares expected to start trading on Nasdaq July 14.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Primaris REIT Says Completed $154M Strategic Disposition and Provided Financing Update
Primaris REIT Says Completed $154M Strategic Disposition and Provided Financing Update
Mar 10, 2026
05:42 PM EST, 12/22/2025 (MT Newswires) -- Primaris Real Estate Investment Trust (PMZ-UN.TO) after trade Monday said it completed the sale of Northland Village and Northland Professional Centre in Calgary for $154 million to a Canadian institutional investor on Dec. 19. Northland Village, a recently redeveloped open-air centre in northwest Calgary, is anchored by Walmart, Winners, Best Buy, GoodLife and...
Amneal Reports FDA Approval of Denosumab Biosimilars
Amneal Reports FDA Approval of Denosumab Biosimilars
Mar 10, 2026
04:35 PM EST, 12/22/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) and partner mAbxience said late Monday that the US Food and Drug Administration has approved their denosumab biosimilars, Boncresa and Oziltus. Boncresa is a biosimilar referencing Prolia, and Oziltus is a biosimilar referencing XGEVA, they said. Under the partnership, mAbxience develops and manufactures the drugs, while Amneal holds...
Synopsys Insider Sold Shares Worth $1,685,036, According to a Recent SEC Filing
Synopsys Insider Sold Shares Worth $1,685,036, According to a Recent SEC Filing
Mar 10, 2026
05:42 PM EST, 12/22/2025 (MT Newswires) -- Shelagh Glaser, CFO, on December 19, 2025, sold 3,657 shares in Synopsys ( SNPS ) for $1,685,036. Following the Form 4 filing with the SEC, Glaser has control over a total of 17,842 common shares of the company, with 17,842 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/883241/000186550425000010/xslF345X05/edgardoc.xml ...
Report says Amtrak's new higher-speed trains delayed by planning, track issues  
Report says Amtrak's new higher-speed trains delayed by planning, track issues  
Mar 10, 2026
WASHINGTON, Dec 22 (Reuters) - U.S. passenger railroad Amtrak's next-generation high-speed Acela train cars ‌were delayed by ​more than four years ‍due to planning, ⁠design ⁠and track issues and a ‌desire ​for higher speeds that has not ⁠materialized, a ‍Senate ​report issued late on Monday said. Amtrak's $2.3 billion program ‍to replace its high-speed trains along the northeast U.S. corridor...
Copyright 2023-2026 - www.financetom.com All Rights Reserved